EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands

Naomi Scarano iD, Stefano Espinoza, Chiara Brullo iD, Elena Cichero

International Journal of Molecular Sciences · 27.07.2024 · 25 (15) · 8226

DOI: 10.3390/ijms25158226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.07.2024. Verfasst von Naomi Scarano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Section of Medicinal Chemistry, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Benedetto XV, 3, 16…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Drug Discovery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Genoa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G-protein-coupled receptors (GPCRs) represent a family of druggable targets when treating several diseases and continue to be a leading part of the drug discovery process. Trace amine-associated receptors (TAARs) are GPCRs involved in many physiological functions with TAAR1 having important roles within the central nervous system (CNS). By using homology modeling methods, the responsiveness of TAAR1 to endogenous and synthetic ligands has been explored. In addition, the discovery of different chemo-types as selective murine and/or human TAAR1 ligands has helped in the understanding of the species-specificity preferences. The availability of TAAR1–ligand complexes sheds light on how different ligands bind TAAR1. TAAR5 is considered an olfactory receptor but has specific involvement in some brain functions. In this case, the drug discovery effort has been limited. Here, we review the successful computational efforts developed in the search for novel TAAR1 and TAAR5 ligands. A specific focus on applying structure-based and/or ligand-based methods has been done. We also give a perspective of the experimental data available to guide the future drug design of new ligands, probing species-specificity preferences towards more selective ligands. Hints for applying repositioning approaches are also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledDrug DiscoveryLigandsHumansAnimalsMolecular Docking SimulationProtein BindingTrace Amine-Associated Receptors

Stichwörter der Autor:innen

TAAR1TAAR5dockingdrug designmolecular modelingmutagenesis

Substanzen

Receptors, G-Protein-CoupledLigandsTrace Amine-Associated Receptors

Autor:innen und Institutionen

  • Department of Pharmacy, Section of Medicinal Chemistry, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa, Italy.
  • Department of Health Sciences and Research Center on Autoimmune and Allergic Diseases (CAAD), University of Piemonte Orientale (UPO), 28100 Novara, Italy.
  • Central RNA Laboratory, Istituto Italiano di Tecnologia (IIT), 16152 Genova, Italy.

ORCID-Profile: Naomi Scarano, Chiara Brullo

Förderung

  • University of Genoa

Zitieren

APA

Scarano, N., Espinoza, S., Brullo, C., & Cichero, E. (2024). Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands. International Journal of Molecular Sciences, 25(15), 8226. https://doi.org/10.3390/ijms25158226

Vancouver

Scarano N, Espinoza S, Brullo C, Cichero E. Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands. International Journal of Molecular Sciences. 2024;25(15):8226. doi:10.3390/ijms25158226

BibTeX
@article{Scarano2024,
  author = {Scarano, Naomi and Espinoza, Stefano and Brullo, Chiara and Cichero, Elena},
  title = {Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {15},
  pages = {8226},
  doi = {10.3390/ijms25158226}
}
Kostenlos starten →